Overview

The Efficacy of Permethrin 5%, Fusidic Acid 1% and Synthomycine 5% for Demodex - Blepharitis

Status:
Unknown status
Trial end date:
2018-09-01
Target enrollment:
Participant gender:
Summary
The study aims to investigate the effect of Permethrin 5% treatment on Signs and symptoms of Demodex-blepharitis in comparison to Synthomycine 5% and Fucithalmic (fusidic acid 1%) .
Phase:
Phase 4
Details
Lead Sponsor:
Barzilai Medical Center
Treatments:
Fusidic Acid
Ophthalmic Solutions
Permethrin
Tetrahydrozoline